352 Longitudinal Infusion of Insulin-Like Growth Factor-I and Igf-Binding Protein-3 Complex to Five Preterm Infants - Pharmacokinetics and Short Term Safety. (October 2012)
- Record Type:
- Journal Article
- Title:
- 352 Longitudinal Infusion of Insulin-Like Growth Factor-I and Igf-Binding Protein-3 Complex to Five Preterm Infants - Pharmacokinetics and Short Term Safety. (October 2012)
- Main Title:
- 352 Longitudinal Infusion of Insulin-Like Growth Factor-I and Igf-Binding Protein-3 Complex to Five Preterm Infants - Pharmacokinetics and Short Term Safety
- Authors:
- Ley, D
HansenPupp, I
Niklasson, A
Domellöf, M
Friberg, L
Borg, J
Löfquist, C
Hellgren, G
Smith, L
Hård, AL
Hellström, A - Abstract:
- Abstract : Introduction: In preterm infants, low levels of insulin like growth factor-I (IGF-I) and IGF binding protein 3 (IGFBP-3) are associated with impaired brain growth and retinopathy of prematurity (ROP). Treatment with IGF-I/IGFBP-3 may be beneficial for brain development and decrease the prevalence of ROP. Methods: In a phase II pharmacokinetic and safety study, five infants (3 girls) with a median (range) gestational age (GA) of 26+6 (26+0 – 27+2) weeks and birth weight (BW) of 990 (900–1212) g received continuous intravenous infusion of rhIGF-I/rhIGFBP-3. Treatment was initiated during the first postnatal day and continued for a median (range) duration of 168 h (47–168) in doses between 21–111 µg/kg/24h. Results: Treatment with rhIGF-I/rhIGFBP-3 was associated with higher serum IGF-I and IGFBP-3 concentrations (p<0.001) than model-predicted endogenous levels. Out of 74 IGF-I samples measured during study drug infusion, 37 (50%) were within target range, 4 (5%) above and 33 (45%) were below. Predicted dose of rhIGF-I/rhIGFBP-3 to establish circulating levels of IGF-I within the intrauterine range in a 1000 g infant was 75–100 µg/kg/24 h. No hypoglycemia or other adverse effects were recorded. Discussion: Continuous intravenous infusion of rhIGF-I/rhIGFBP-3 was effective in increasing serum concentrations of IGF-I and IGFBP-3. Administration under study conditions was safe.
- Is Part Of:
- Archives of disease in childhood. Volume 97(2012)Supplement 2
- Journal:
- Archives of disease in childhood
- Issue:
- Volume 97(2012)Supplement 2
- Issue Display:
- Volume 97, Issue 2 (2012)
- Year:
- 2012
- Volume:
- 97
- Issue:
- 2
- Issue Sort Value:
- 2012-0097-0002-0000
- Page Start:
- A103
- Page End:
- A103
- Publication Date:
- 2012-10
- Subjects:
- Children -- Diseases -- Periodicals
Infants -- Diseases -- Periodicals
618.920005 - Journal URLs:
- http://adc.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/archdischild-2012-302724.0352 ↗
- Languages:
- English
- ISSNs:
- 0003-9888
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22203.xml